Abstract

Chirality exists in most drugs and has a non-negligible impact on the pharmacological activity, metabolic process, and toxicity of drugs in the human body. Drug molecules can only bind to specific receptor molecules in the human body, and the difference in chirality will lead to different structures of drug molecules, which will lead to the inability of drug molecules to bind to receptor molecules, resulting in a decrease in the efficacy of the drug and even adverse effects on the human body. Therefore, the synthesis of correct chiral drugs has always been an area worth exploring. At present, there are two main approaches for the asymmetric synthesis of chiral drugs: chemical synthesis and biosynthesis. This paper explores the application of chemical synthesis to chiral drugs by combining asymmetric organocatalysis with chemical synthesis. In addition, this paper finds that asymmetric organocatalysis is a very worthwhile way to synthesize chiral drugs and has great potential in the development of new drugs.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call